Syrma Johari MedTech Limited (SJML), a leading medical device design and manufacturing partner, announced the successful conclusion of its participation in The MedTech Conference 2025 (AdvaMed), held from October 6–8, 2025, in the United States.
Hosted by AdvaMed, one of the most influential gatherings in the global MedTech industry, the conference welcomed over 3,700 senior leaders from 44 U.S. states and 38 countries, with more than 150 presenting companies and 500 expert speakers. The event served as a powerful platform for collaboration, partnership building, and exchange of ideas shaping the future of healthcare technology.
Our exhibit reflected SJML’s end-to-end expertise—from product design and prototyping to precision manufacturing and regulatory-compliant production—showcasing our commitment to delivering reliable, high-quality medical devices that advance global MedTech innovation.
On October 7, we presented a keynote session titled “Impactful Innovation is the New Alpha: Profitability with Purpose for Health Equity.” Delivered by Monali Bhansali, Head of Strategy, Business Growth, and James Gist, Senior Director – Business Development, the session explored how we are translating innovation into measurable social impact through regulatory excellence, scalable design practices, and value-driven manufacturing models.
Throughout the event, our booth became a hub for meaningful engagement. We connected with global clients, healthcare innovators, and emerging MedTech companies, exchanging ideas that may shape collaborative opportunities in the months ahead. These interactions underscored our ongoing commitment to advancing accessible, high-quality healthcare solutions and fostering strong partnerships across the MedTech ecosystem.
Reflecting on the experience, Monali Bhansali said, “Our engagement at The MedTech Conference reaffirmed our belief that innovation driven by purpose defines the next era of MedTech. The conversations around equitable healthcare access resonated deeply with our mission—to blend design ingenuity and manufacturing excellence in ways that truly improve patient outcomes worldwide.”
Our participation at AdvaMed 2025 also allowed us to strengthen global relationships and align with healthcare leaders who share a vision for scaling innovation responsibly. As a trusted, end-to-end MedTech partner, we remain dedicated to providing reliable, compliant, and sustainable design and manufacturing solutions that help our clients bring life-changing technologies to patients faster.
Commitment to the Future
As the MedTech industry continues to evolve toward more inclusive and impact-driven innovation, we remain steadfast in our commitment to enabling equitable access to healthcare technologies – demonstrating that meaningful innovation and profitability can successfully move forward together.
